The most common way a Türkiye–Iraq or Türkiye–CIS commercial relationship fails is not fraud, and it is not market misjudgement. It is that the parties agreed on the commercial terms and never agreed on how money moves.
Two competent companies sign, ship, and then spend four months discovering that the buyer's bank will not process the payment structure the seller's bank requires, that the documentation each side considers standard is unfamiliar to the other, and that neither has a governing-law provision either could realistically enforce. The trade was sound. The infrastructure around it was assumed.
Why these corridors reward institutional structure
Trade between Türkiye and Iraq, Uzbekistan, and the wider CIS is substantial and growing. It is also structurally different from EU-facing trade in ways that determine how a company should enter.
Relationship precedes transaction. In much of the EU, a compliant contract with an unknown counterparty is a workable basis for business. In these corridors it is usually not. Counterparty verification runs through relationships and institutions, and a company arriving without either is treated with reasonable caution.
Institutional standing substitutes for track record. Chamber of commerce membership, trade delegation participation, and verified corporate registration carry weight because they are checkable in an environment where credit information is thin.
Settlement is the hard part. Correspondent banking coverage is uneven, currency convertibility varies, and payment routes that work between two specific banks may not generalise. This is a solvable problem and it must be solved before the first shipment, not after the first invoice.
Local legal form determines what is possible. Whether a company can hold contracts, employ staff, import in its own name, or repatriate profit depends on the entity structure chosen at entry — and restructuring after the fact is expensive and slow.
Corporate structuring
The entry structure decision comes first because everything downstream inherits it.
Representative office. Suitable for market development, relationship building, and coordination. Cannot generally trade in its own name. Low cost, fast, limited. A reasonable first step where the market is unproven.
Local subsidiary. Full commercial capacity — contracting, employment, import, banking. Higher establishment cost, ongoing compliance and reporting obligations, and a defined exit process. Appropriate where trade volume justifies it or where local presence is a customer requirement.
Local partner or distributor. Fastest market access with the least capital exposure, and the highest dependency risk. Distribution agreements in these markets need explicit performance terms, defined territory and exclusivity boundaries, IP protection, and a workable termination mechanism. Exclusivity granted without performance conditions is the most frequently regretted clause in this category of agreement.
Branch of the Turkish entity. Sits between representative office and subsidiary in most jurisdictions, with tax and liability consequences specific to each. Requires jurisdiction-specific analysis rather than a general rule.
The choice is not permanent, but the migration cost between forms is real. Selecting on the twelve-to-eighteen-month plan rather than the first order is consistently the better decision.
Commercial representation
For companies not yet establishing an entity, representation provides commercial presence without structural commitment.
In practice this means acting as the local commercial interface: attending on the company's behalf, managing counterparty communication in local language, verifying prospective partners, coordinating with chambers and trade bodies, and providing on-the-ground assessment that cannot be obtained remotely.
The value is concentrated in counterparty verification. Written confirmation that a prospective partner is registered, active, and has a functioning operation is worth more than any market report, and it is not reliably obtainable from outside the market.
Settlement structuring
This is where engagements most often begin, because it is where companies most often become stuck.
The core questions:
What payment instrument is realistic for both parties? Letter of credit, documentary collection, advance payment, open account — each carries a different risk allocation and a different cost, and availability depends on both parties' banking relationships rather than on preference.
What currency, and who carries the FX exposure? An unspecified currency clause allocates the risk by default, usually to whoever noticed last.
What is the actual banking route? Not the theoretical one. Which correspondent chain will carry the payment, what documentation each institution requires, and what compliance screening applies. This is testable in advance with a small transaction, and testing it is dramatically cheaper than discovering it on a full shipment value.
What happens on dispute? Governing law, forum, and — the question that matters most — whether the resulting award is enforceable where the counterparty's assets actually are. A judgment nobody can enforce is a document.
Our compliance framework covers the AML and sanctions screening applied to any settlement structuring work, which in these corridors is not optional and not a formality.
The chamber relationship
Working with chambers of commerce in Iraq, Uzbekistan and CIS commerce hubs is a substantive part of how these engagements function.
Chambers provide three things a private firm cannot generate on its own: verification of counterparty registration and standing; introduction with institutional weight behind it; and sectoral visibility into which local businesses are active and seeking partners, which is not reliably available through any published source.
In exchange, chambers want credible counterparties for their members. That reciprocity is what makes the relationship durable, and it is also why it cannot be shortcut — chamber relationships are built by delivering acceptable partners repeatedly, not by joining.
Where companies go wrong
Consistent patterns, across many engagements:
Entering on a single counterparty relationship. One enthusiastic local partner is a fragile market position. When the relationship ends, the market access ends with it.
Copying the EU contract. Terms drafted for an EU counterparty carry assumptions about legal process, banking, and enforcement that do not transfer. The document may be excellent and still be inoperative.
Treating compliance screening as bureaucracy. Sanctions and AML exposure in these corridors is a real commercial risk with severe consequences, and screening is the cheap part of managing it.
Underestimating time. Entity establishment, banking, and first shipment realistically takes several months. Plans built on weeks generate pressure that produces bad structural decisions.
No exit plan. Distribution agreements without termination mechanisms, and entities without a defined wind-down path, become expensive commitments to markets that did not perform.
What we do
Corporate structuring, commercial representation, and cross-border settlement advisory — delivered as one engagement rather than three, because the settlement route constrains the entity choice and the entity choice constrains the contracting position. Sequencing them separately is how companies end up with a structure that cannot execute the trade it was built for.
The outcome we work toward is verified B2B procurement pipelines and durable institutional relationships in the destination market, rather than a single transaction.
More on the group's cross-border trade practice is set out under business units and about us. To discuss a specific market, contact the team.
